A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris
Clinical trial NCT06248008 · COMPLETED
Trial details
- NCT number
- NCT06248008
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-18
- Primary completion
- 2025-11-12
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.